Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 210

1.

Bacterial azurin in potential cancer therapy.

Chakrabarty AM.

Cell Cycle. 2016 Jul 2;15(13):1665-6. doi: 10.1080/15384101.2016.1179034. Epub 2016 Apr 22. No abstract available.

2.

Structural studies on Laz, a promiscuous anticancer Neisserial protein.

Hashimoto W, Ochiai A, Hong CS, Murata K, Chakrabarty AM.

Bioengineered. 2015;6(3):141-8. doi: 10.1080/21655979.2015.1022303. Epub 2015 Feb 25.

3.

Bacterial proteins and peptides in cancer therapy: today and tomorrow.

Chakrabarty AM, Bernardes N, Fialho AM.

Bioengineered. 2014 Jul-Aug;5(4):234-42. doi: 10.4161/bioe.29266. Epub 2014 May 29. Review.

4.

Microbial pathogenicity: a new approach to drug development.

Chakrabarty AM.

Adv Exp Med Biol. 2014;808:41-9. doi: 10.1007/978-81-322-1774-9_4.

PMID:
24595609
5.

Genome Sequence of the 2,4,5-Trichlorophenoxyacetate-Degrading Bacterium Burkholderia phenoliruptrix Strain AC1100.

Xu P, Yu H, Chakrabarty AM, Xun L.

Genome Announc. 2013 Aug 8;1(4). pii: e00600-13. doi: 10.1128/genomeA.00600-13.

6.

Engineering of bacterial strains and their products for cancer therapy.

Bernardes N, Chakrabarty AM, Fialho AM.

Appl Microbiol Biotechnol. 2013 Jun;97(12):5189-99. doi: 10.1007/s00253-013-4926-6. Epub 2013 May 4. Review.

PMID:
23644748
7.

Patent controversies and court cases: cancer diagnosis, therapy and prevention.

Fialho AM, Chakrabarty AM.

Cancer Biol Ther. 2012 Nov;13(13):1229-34. doi: 10.4161/cbt.21958. Epub 2012 Sep 6. Review.

8.

Overcoming drug resistance in multi-drug resistant cancers and microorganisms: a conceptual framework.

Avner BS, Fialho AM, Chakrabarty AM.

Bioengineered. 2012 Sep-Oct;3(5):262-70. doi: 10.4161/bioe.21130. Epub 2012 Jul 3. Review.

9.

Glioblastoma multiforme: novel therapeutic approaches.

Fialho AM, Salunkhe P, Manna S, Mahali S, Chakrabarty AM.

ISRN Neurol. 2012;2012:642345. doi: 10.5402/2012/642345. Epub 2012 Feb 8.

10.

Recent patents on live bacteria and their products as potential anticancer agents.

Fialho AM, Bernardes N, Chakrabarty AM.

Recent Pat Anticancer Drug Discov. 2012 Jan;7(1):31-55. Review.

PMID:
21906014
11.

Law-medicine interfacing: patenting of human genes and mutations.

Fialho AM, Chakrabarty AM.

Recent Pat DNA Gene Seq. 2011 Aug;5(2):81-5.

PMID:
21574951
12.

Bioengineered bugs, drugs and contentious issues in patenting.

Chakrabarty AM.

Bioeng Bugs. 2010 Jan-Feb;1(1):2-8. doi: 10.4161/bbug.1.1.9850.

13.

Microbial-based therapy of cancer: current progress and future prospects.

Bernardes N, Seruca R, Chakrabarty AM, Fialho AM.

Bioeng Bugs. 2010 May-Jun;1(3):178-90. doi: 10.4161/bbug.1.3.10903. Epub 2009 Dec 2. Review.

14.

Bacterial proteins as potential drugs in the treatment of leukemia.

Kwan JM, Fialho AM, Kundu M, Thomas J, Hong CS, Das Gupta TK, Chakrabarty AM.

Leuk Res. 2009 Oct;33(10):1392-9. doi: 10.1016/j.leukres.2009.01.024. Epub 2009 Feb 27.

PMID:
19250673
15.

Noncationic peptides obtained from azurin preferentially enter cancer cells.

Taylor BN, Mehta RR, Yamada T, Lekmine F, Christov K, Chakrabarty AM, Green A, Bratescu L, Shilkaitis A, Beattie CW, Das Gupta TK.

Cancer Res. 2009 Jan 15;69(2):537-46. doi: 10.1158/0008-5472.CAN-08-2932.

16.

Leishmania-released nucleoside diphosphate kinase prevents ATP-mediated cytolysis of macrophages.

Kolli BK, Kostal J, Zaborina O, Chakrabarty AM, Chang KP.

Mol Biochem Parasitol. 2008 Apr;158(2):163-75. doi: 10.1016/j.molbiopara.2007.12.010. Epub 2007 Dec 25.

17.

Recent patents on bacterial proteins as potential anticancer agents.

Fialho AM, Chakrabarty AM.

Recent Pat Anticancer Drug Discov. 2007 Nov;2(3):224-34. Review.

PMID:
18221065
18.

Azurin-like protein blocks invasion of Toxoplasma gondii through potential interactions with parasite surface antigen SAG1.

Naguleswaran A, Fialho AM, Chaudhari A, Hong CS, Chakrabarty AM, Sullivan WJ Jr.

Antimicrob Agents Chemother. 2008 Feb;52(2):402-8. Epub 2007 Dec 10.

19.

Beyond host-pathogen interactions: microbial defense strategy in the host environment.

Fialho AM, Stevens FJ, Das Gupta TK, Chakrabarty AM.

Curr Opin Biotechnol. 2007 Jun;18(3):279-86. Epub 2007 Apr 23. Review.

PMID:
17451932
20.

Cupredoxin-cancer interrelationship: azurin binding with EphB2, interference in EphB2 tyrosine phosphorylation, and inhibition of cancer growth.

Chaudhari A, Mahfouz M, Fialho AM, Yamada T, Granja AT, Zhu Y, Hashimoto W, Schlarb-Ridley B, Cho W, Das Gupta TK, Chakrabarty AM.

Biochemistry. 2007 Feb 20;46(7):1799-810. Epub 2007 Jan 24.

PMID:
17249693
21.

Bacterial proteins and CpG-rich extrachromosomal DNA in potential cancer therapy.

Mahfouz M, Hashimoto W, Das Gupta TK, Chakrabarty AM.

Plasmid. 2007 Jan;57(1):4-17. Epub 2006 Dec 12. Review.

PMID:
17166586
22.

Disrupting the entry barrier and attacking brain tumors: the role of the Neisseria H.8 epitope and the Laz protein.

Hong CS, Yamada T, Hashimoto W, Fialho AM, Das Gupta TK, Chakrabarty AM.

Cell Cycle. 2006 Aug;5(15):1633-41. Epub 2006 Aug 1.

PMID:
16861907
23.

Azurin, Plasmodium falciparum malaria and HIV/AIDS: inhibition of parasitic and viral growth by Azurin.

Chaudhari A, Fialho AM, Ratner D, Gupta P, Hong CS, Kahali S, Yamada T, Haldar K, Murphy S, Cho W, Chauhan VS, Das Gupta TK, Chakrabarty AM.

Cell Cycle. 2006 Aug;5(15):1642-8. Epub 2006 Aug 1.

PMID:
16861897
24.

Human cytochrome c enters murine J774 cells and causes G1 and G2/M cell cycle arrest and induction of apoptosis.

Hiraoka Y, Granja AT, Fialho AM, Schlarb-Ridley BG, Das Gupta TK, Chakrabarty AM, Yamada T.

Biochem Biophys Res Commun. 2005 Dec 16;338(2):1284-90. Epub 2005 Oct 24.

PMID:
16256942
25.

Internalization of bacterial redox protein azurin in mammalian cells: entry domain and specificity.

Yamada T, Fialho AM, Punj V, Bratescu L, Gupta TK, Chakrabarty AM.

Cell Microbiol. 2005 Oct;7(10):1418-31.

PMID:
16153242
26.

Genetics research and the judicial decisions.

Chakrabarty AM.

Not Polit. 2002;18(65):99-102. No abstract available.

PMID:
15505918
27.

Rusticyanin, a bacterial electron transfer protein, causes G1 arrest in J774 and apoptosis in human cancer cells.

Yamada T, Hiraoka Y, Das Gupta TK, Chakrabarty AM.

Cell Cycle. 2004 Sep;3(9):1182-7. Epub 2004 Sep 1.

PMID:
15467448
28.

Regulation of mammalian cell growth and death by bacterial redox proteins: relevance to ecology and cancer therapy.

Yamada T, Hiraoka Y, Das Gupta TK, Chakrabarty AM.

Cell Cycle. 2004 Jun;3(6):752-5. Epub 2004 Jun 14. Review.

PMID:
15153808
29.

Modulation of mammalian cell growth and death by prokaryotic and eukaryotic cytochrome c.

Hiraoka Y, Yamada T, Goto M, Das Gupta TK, Chakrabarty AM.

Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6427-32. Epub 2004 Apr 13.

30.

Apoptosis or growth arrest: Modulation of tumor suppressor p53's specificity by bacterial redox protein azurin.

Yamada T, Hiraoka Y, Ikehata M, Kimbara K, Avner BS, Das Gupta TK, Chakrabarty AM.

Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4770-5. Epub 2004 Mar 24.

31.

Bacterial cupredoxin azurin as an inducer of apoptosis and regression in human breast cancer.

Punj V, Bhattacharyya S, Saint-Dic D, Vasu C, Cunningham EA, Graves J, Yamada T, Constantinou AI, Christov K, White B, Li G, Majumdar D, Chakrabarty AM, Das Gupta TK.

Oncogene. 2004 Mar 25;23(13):2367-78.

PMID:
14981543
32.

Patenting life forms: yesterday, today, and tomorrow.

Chakrabarty AM.

Adv Genet. 2003;50:3-11; discussion 507-10. No abstract available.

PMID:
14714683
33.

Bacterial cupredoxin azurin and its interactions with the tumor suppressor protein p53.

Punj V, Das Gupta TK, Chakrabarty AM.

Biochem Biophys Res Commun. 2003 Dec 5;312(1):109-14. Review. No abstract available.

PMID:
14630027
34.

Environmental biotechnology in the postgenomics era.

Chakrabarty AM.

Biotechnol Adv. 2003 Dec;22(1-2):3-8. Review.

PMID:
14623038
35.

Crossing species boundaries and making human-nonhuman hybrids: moral and legal ramifications.

Chakrabarty AM.

Am J Bioeth. 2003 Summer;3(3):20-1. No abstract available.

PMID:
14594473
36.

Microbial genes and enzymes in the degradation of chlorinated compounds.

Ogawa N, Miyashita K, Chakrabarty AM.

Chem Rec. 2003;3(3):158-71. Review.

PMID:
12900936
37.

Ethics in biomedical research: practical considerations.

Chakrabarty AM.

Am J Bioeth. 2002 Fall;2(4):53-4. No abstract available.

PMID:
12762927
38.

Energy-generating enzymes of Burkholderia cepacia and their interactions with macrophages.

Punj V, Sharma R, Zaborina O, Chakrabarty AM.

J Bacteriol. 2003 May;185(10):3167-78.

39.

Microorganisms and cancer: quest for a therapy.

Chakrabarty AM.

J Bacteriol. 2003 May;185(9):2683-6. Review. No abstract available.

40.

Redox proteins in mammalian cell death: an evolutionarily conserved function in mitochondria and prokaryotes.

Punj V, Chakrabarty AM.

Cell Microbiol. 2003 Apr;5(4):225-31. Review.

PMID:
12675680
41.
42.

The bacterial redox protein azurin induces apoptosis in J774 macrophages through complex formation and stabilization of the tumor suppressor protein p53.

Yamada T, Goto M, Punj V, Zaborina O, Kimbara K, Das Gupta TK, Chakrabarty AM.

Infect Immun. 2002 Dec;70(12):7054-62.

43.

Bacterial redox protein azurin, tumor suppressor protein p53, and regression of cancer.

Yamada T, Goto M, Punj V, Zaborina O, Chen ML, Kimbara K, Majumdar D, Cunningham E, Das Gupta TK, Chakrabarty AM.

Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14098-103. Epub 2002 Oct 22.

44.

Compulsory licensure: the case of Cipro and beyond.

Chakrabarty AM.

Am J Bioeth. 2002 Summer;2(3):40. No abstract available.

PMID:
12230853
45.

Adenylate kinase as a virulence factor of Pseudomonas aeruginosa.

Markaryan A, Zaborina O, Punj V, Chakrabarty AM.

J Bacteriol. 2001 Jun;183(11):3345-52.

46.
47.

Phagocytic cell killing mediated by secreted cytotoxic factors of Vibrio cholerae.

Punj V, Zaborina O, Dhiman N, Falzari K, Bagdasarian M, Chakrabarty AM.

Infect Immun. 2000 Sep;68(9):4930-7.

48.

Clinical and environmental isolates of Burkholderia cepacia exhibit differential cytotoxicity towards macrophages and mast cells.

Melnikov A, Zaborina O, Dhiman N, Prabhakar BS, Chakrabarty AM, Hendrickson W.

Mol Microbiol. 2000 Jun;36(6):1481-93.

Supplemental Content

Loading ...
Support Center